炎症相关疾病中髓样细胞表达的激发受体-1研究进展
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金面上项目(30772138).


Triggering receptor expressed on myeloid cells-1 and inflammation-associated diseases: recent progress
Author:
Affiliation:

Fund Project:

Supported by National Natural Science Foundation of China(30772138).

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    髓样细胞表达的激发受体-1(triggering receptors expressed by myeloid cells-1,TREM-1)是新近发现的参与单核细胞作用和炎症反应的分子,是自然杀伤细胞受体家族成员,表达于中性粒细胞、成熟单核细胞及巨噬细胞,能增强由Toll样受体(TLR)-2和-4启动的炎症反应,扩大急、慢炎症反应。细菌或真菌感染患者体液中可检测到可溶性TREM-1(sTREM-1),提示其可作为感染的诊断指标;针对TREM-1的靶标治疗是值得深入探讨的抗炎治疗新方法。本文就炎症相关疾病中TREM-1的研究进展作一综述。

    Abstract:

    Triggering receptor expressed on myeloid cells-1(TREM)-1,a recently identified molecule,is involved in monocytic activation and inflammatory responses.TREM-1 is a member of natural killer cell receptor family and is expressed on neutrophils,mature monocytes and macrophages,and it can enhance the inflammatory responses mediated by Toll-like receptor-2 and -4,showing a role of inflammation promotion.Reportedly sTREM-1 was detectable in the body fluids in the presence of bacterial or fungal infection; therefore it might be used as a marker for inflammation.In addition,recombinant sTREM-1 may also be a new method for anti-inflammatory therapy.Recently,it has been found that TREM-1 not only promoted the acute inflammatory responses,but also participated in the development of chronic inflammation.This review summarizes the role of TREM-1 in the inflammation-associated dieases.

    参考文献
    相似文献
    引证文献
相关视频

分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2009-02-03
  • 最后修改日期:2009-06-25
  • 录用日期:2009-09-27
  • 在线发布日期: 2009-10-26
  • 出版日期:
文章二维码
重要通知
友情提醒: 近日发现论文正式见刊或网络首发后,有人冒充我刊编辑部名义给作者发邮件,要求添加微信,此系诈骗行为!可致电编辑部核实:021-81870792。
            《海军军医大学学报》编辑部
关闭